Cystic fibrosis phenotype evaluation and paternity outcome in 50 males with congenital bilateral absence of vas deferens

Citation
Rn. Josserand et al., Cystic fibrosis phenotype evaluation and paternity outcome in 50 males with congenital bilateral absence of vas deferens, HUM REPR, 16(10), 2001, pp. 2093-2097
Citations number
14
Categorie Soggetti
Reproductive Medicine","da verificare
Journal title
HUMAN REPRODUCTION
ISSN journal
02681161 → ACNP
Volume
16
Issue
10
Year of publication
2001
Pages
2093 - 2097
Database
ISI
SICI code
0268-1161(200110)16:10<2093:CFPEAP>2.0.ZU;2-2
Abstract
BACKGROUND: Most infertile males with congenital bilateral absence of vas d eferens; (CBAVD) carry mutations on the cystic fibrosis transmembrane condu ctance regulator gene and may express mild cystic fibrosis (CF) symptoms. B arriers to paternity for these men can now be overcome by assisted reproduc tion. Our aims were to investigate the CF-related phenotype and clinical ou tcome for 50 patients with CBAVD seen at a CF adult centre between 1992 and 1999. METHODS AND RESULTS: The investigation of the patients included scre ening for 22 CF mutations and identification of the poly-T variant of intro n 8, sweat testing, clinical investigation for CF-related extra-genital man ifestations, and genetic counselling. CFTR mutations were detected on 56 al leles of the 50 patients. A total of 15 (30%) was compound heterozygote and 26 (52%) heterozygote. In all, 38% of the patients had a positive sweat te st. Four patients were diagnosed with typical CIT not detected previously. Twenty-one patients became fathers following ICSI (eight cases), artificial insemination by donor or IVF with sperm donor (seven cases) or through ado ption (six cases). A mail survey allowed the identification of CF-related c linical symptoms. Information on the occurrence of CF-related symptoms was obtained for 58.5% of patients: in the absence of initial symptoms, no new clinical signs were reported. CONCLUSION: Patients diagnosed with CBAVD nee d genetic counselling before assisted reproduction. Even when no wish for p aternity is expressed, CF gene screening should be associated with at least a sweat test and clinical evaluation because of possible mild forms of CF disease. Medical follow-up did not reveal any new symptoms.